What Directors Should Be Asking About Innovation: A Board-Level Diagnostic

• The Oversight Gap Boards Already Recognise
• Lagging Indicators Tell You It Is Already Too Late
• The Board Questions That Reveal Innovation Flow
• Red Flags in Standard Innovation Reporting
• The Nordic and European Governance Dimension
• From Diagnostic to Governance Practice
• Conclusion
• References

Boards see innovation through the rear-view mirror. A small set of leading indicators and sharper questions would let them see the road ahead

The Oversight Gap Boards Already Recognise

Boards have learned, sometimes the hard way, that some of the most consequential dimensions of a business are the ones hardest to see from the boardroom. Technology governance is the clearest recent example. For years, boards dealt with technology on the periphery — as a subtopic within the risk and audit committee — until it became clear that digital and AI capability was a leading determinant of competitive position. Even now, the gap persists: McKinsey reports that only around 15% of boards receive AI-related metrics, and that 66% of directors describe their board as having limited to no knowledge or experience with AI. The best boards responded by giving technology structured oversight, the right questions, and meaningful indicators.

Innovation sits in a similar blind spot — and it is arguably a more fundamental one, because innovation is the mechanism by which a company renews its own competitive position. Yet most boards oversee innovation through a handful of lagging indicators: R&D spend, patent counts, number of pilots launched, revenue from new products. These are not wrong, but they are all rear-view. They report what has already happened, long after the point at which a board could have influenced it.

The Bridgium research with 28 innovation leaders across Nordic and European enterprises offers boards something the standard metrics do not: a set of leading indicators for innovation health, and a small number of precise questions that reveal whether innovation is actually flowing through the organisation — or quietly stalling in ways that will only appear in the financials years later. This is not an operational matter that belongs below the board. It is exactly the kind of forward-looking oversight that distinguishes an effective board from one that only reviews and approves.

Lagging Indicators Tell You It Is Already Too Late

The distinction between lagging and leading indicators is familiar to every board through financial oversight. Lagging indicators (last quarter’s revenue) report outcomes; leading indicators (pipeline health) predict them. Boards learned long ago not to govern on lagging financial indicators alone. Innovation governance has not yet made the same shift.

The problem with a purely lagging view is timing. By the time weak innovation shows up in new-product revenue or market-share erosion, the structural causes have been operating for years — and the window in which the board could have prompted a course correction has closed. Leading indicators of innovation flow move the board’s visibility upstream, to the point where oversight can still make a difference.

“Innovation without recognition becomes invisible work.”
— CEO · IT Services · Finland

This observation has a direct board-level implication: what the organisation does not measure, the board cannot see. If innovation contribution is invisible to the performance system, it is doubly invisible to the board — and the board is, in effect, governing a critical capability with the lights off.

The Board Questions That Reveal Innovation Flow

The Bridgium framework maps innovation as a flow through three stages, each with a characteristic failure. A board does not need to understand the operational detail of each stage. It needs a small number of questions — one per stage — that surface whether the flow is healthy. These questions are designed to be asked of management, and the quality of the answer is itself diagnostic.

The elegance of these questions is that a board does not need innovation expertise to interpret the answers. A confident, specific, evidence-backed response indicates a healthy flow at that stage. A vague, anecdotal, or “we don’t measure that” response is itself the finding. The board is not assessing the innovation — it is assessing whether management can see its own innovation flow. A management team that cannot answer these questions is not necessarily failing at innovation, but it is certainly flying without instruments.

Red Flags in Standard Innovation Reporting

Beyond the three questions, the Bridgium framework helps directors recognise specific patterns in the innovation reporting they already receive — patterns that look like health but signal a stall.

None of these patterns is proof of a problem. Each is a prompt for a better question. The board’s role is not to diagnose the operational cause — that is management’s work — but to notice when reassuring numbers may be masking a stall, and to ask management to look closer.

The Nordic and European Governance Dimension

Governance structures vary across the markets where this question matters most. The Nordics generally use a single-tier board with strong norms of independence and consensus; the DACH region (notably Germany) uses a two-tier structure separating the supervisory board (Aufsichtsrat) from the management board (Vorstand). These differences shape how innovation oversight can work in practice.

In two-tier systems, the supervisory board is structurally more distant from operations, which makes leading indicators even more valuable — they give a supervisory board a legitimate, non-operational window into innovation health without crossing into management’s domain. In consensus-oriented Nordic boards, the three questions fit naturally into a culture that already values probing dialogue over rubber-stamping. In both cases, the flow metrics offer directors something their governance model needs: a way to exercise meaningful oversight of innovation without either ignoring it or overstepping into execution.

There is also a co-determination dimension in parts of the region: where employee representatives sit on boards, they often have direct sight of exactly the frontline signals — the Stage 1 observations — that leading indicators are designed to surface. A board that takes innovation flow seriously can treat these representatives as a genuine source of leading-indicator insight rather than a compliance formality.

From Diagnostic to Governance Practice

1. Add innovation flow to the board agenda deliberately. As with technology governance, the first step is to move innovation from an occasional, peripheral topic to a structured one — with a defined place on the agenda and a small set of leading indicators reviewed regularly, not only when a major initiative succeeds or fails.
2. Ask for leading indicators, not just lagging ones. Request that management report the flow metrics — articulation, stabilisation, handover, and integration — alongside the conventional R&D and pipeline figures. Even rough estimates of these move the board’s view upstream. The act of asking often prompts management to build visibility it did not previously have.
3. Use the three questions as a standing diagnostic. The three stage questions can be asked at any innovation or strategy review. Asked consistently over time, they reveal trends — whether the quality of management’s answers is improving, and whether the flow is strengthening or eroding.
4. Treat the ability to answer as a capability signal. A management team that can answer these questions with evidence has visibility into its own innovation flow — a capability in itself. Helping management build that visibility, where it is absent, is a legitimate and high-value contribution for a board to make.

Conclusion

Boards have already learned that overseeing a critical capability through lagging indicators alone leaves them governing the past. They made the shift for financial performance long ago, and are making it now for technology and AI. Innovation is the next frontier of the same evolution — and arguably the most important, because innovation is how the company renews the competitive position the board is charged with protecting.

The tools required are not elaborate. A small set of leading indicators, three well-chosen questions, and the discipline to notice when reassuring reports may be masking a stall. None of this crosses into management’s operational domain; all of it strengthens the board’s forward-looking oversight. The best boards will not wait until weak innovation appears in the financials to act. They will ask the questions that reveal it while there is still time to influence the outcome.

The question for any board is simple: does the innovation reporting we receive tell us whether ideas are actually flowing through this organisation — or only what has already happened? If it is the latter, better questions are available.

The Bridgium Innovation Flow Checklist offers boards and management a shared, structured diagnostic
bridgium-research.eu/innovation-checklist-2026/
Full research report:
bridgium-research.eu/innovation-report-2026/

References

1. McKinsey & Company, “How Effective Boards Approach Technology Governance,” McKinsey Digital (2022). Read
2. McKinsey & Company, “The AI Reckoning: How Boards Can Evolve,” McKinsey (2025). Read
3. Huber, C., Sukharevsky, A. & Zemmel, R., “Five Questions Boards Should Be Asking About Digital Transformation,” Harvard Business Review (2021). Read
4. McKinsey & Company, “What Is a Board of Directors?” McKinsey Explainers (2023). Read
5. Kaplan, R.S. & Norton, D.P., The Balanced Scorecard: Translating Strategy into Action, Harvard Business School Press (1996). Publisher
6. Kerr, S., “On the Folly of Rewarding A, While Hoping for B,” Academy of Management Journal (1975). JSTOR
7. Burt, R.S., Structural Holes: The Social Structure of Competition, Harvard University Press (1992). Publisher
8. Berger, P.L. & Luckmann, T., The Social Construction of Reality, Doubleday (1966). Publisher
9. National Association of Corporate Directors, “2025 Board Practices and Oversight Survey,” NACD (2025). Read
10. OECD, G20/OECD Principles of Corporate Governance, OECD Publishing (2023). Read
11. Weick, K.E., Sensemaking in Organizations, Sage Publications (1995). Publisher
12. Bridgium, How Innovation Happens: Research Report, Albi Marketing Oy & Digitune Oy (2025). Read